🇺🇸 FDA

Intelligence · Patent portfolio

Vertex Pharmaceuticals (Australia) Patents

Full USPTO pharma patent portfolio for Vertex Pharmaceuticals (Australia) — grant dates, expiration, and drug cross-links.

Patents
991
Expiring ≤24m
63

Quick answer

Vertex Pharmaceuticals (Australia) has 991 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 63 expire within 24 months — use filters for patent-cliff planning.

Page 20 of 21

  1. US 6716860

    Azo amino acids derivatives

    Expires Mon Apr 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  2. US 6706711

    Pyrazole derived kinase inhibitor

    Expires Mon Mar 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  3. US 6699865

    Pyrazole compositions useful as inhibitors of ERK

    Expires Mon Feb 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  4. US 6696452

    Pyrazole compounds useful as protein kinase inhibitors

    Expires Mon Feb 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  5. US 6693108

    Inhibitors of c-JUN N terminal kinases (JNK) and other protein kinases

    Expires Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  6. US 6689778

    Inhibitors of Src and Lck protein kinases

    Expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  7. US 6689784

    Carbamate caspase inhibitors and uses thereof

    Expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  8. US 6677359

    N-substituted glycine derivatives

    Expires Mon Jan 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  9. US 6664247

    Pyrazole compounds useful as protein kinase inhibitors

    Expires Mon Dec 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  10. US 6660748

    Bicyclic derivatives

    Expires Mon Dec 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  11. US 6660731

    Pyrazole compounds useful as protein kinase inhibitors

    Expires Mon Dec 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  12. US 6656939

    Pyrazole compounds useful as protein kinase inhibitors

    Expires Mon Nov 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  13. US 6653301

    Pyrazole compounds useful as protein kinase inhibitors

    Expires Mon Nov 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  14. US 6653309

    Inhibitors of IMPDH enzyme technical field of the invention

    Expires Mon Nov 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  15. US 6653300

    Pyrazole compounds useful as protein kinase inhibitors

    Expires Mon Nov 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  16. US 6649640

    Isoxazole compositions useful as inhibitors of ERK

    Expires Mon Nov 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  17. US 6642227

    Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases

    Expires Mon Oct 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  18. US 6638926

    Pyrazole compounds useful as protein kinase inhibitors

    Expires Mon Oct 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  19. US 6635644

    Inhibitors of p38

    Expires Mon Oct 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  20. US 6632809

    Gyrase inhibitors and uses thereof

    Expires Mon Oct 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  21. US 6632945

    Inhibitors of P38

    Expires Mon Oct 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  22. US 6632962

    Caspase inhibitors and uses thereof

    Expires Mon Oct 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  23. US 6624166

    Pyridazines as interleukin-1&bgr; converting enzyme inhibitors

    Expires Mon Sep 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  24. US 6617350

    Inhibitors of aspartyl protease

    Expires Mon Sep 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  25. US 6617309

    Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

    Expires Mon Sep 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  26. US 6613776

    Pyrazole compounds useful as protein kinase inhibitors

    Expires Mon Aug 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  27. US 6613743

    Sulfonamide inhibitors of aspartyl protease

    Expires Mon Aug 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  28. US 6608067

    Inhibitors of serine proteases, particularly HCV NS3 protease

    Expires Mon Aug 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  29. US 6608060

    Inhibitors of p38

    Expires Mon Aug 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  30. US 6608087

    Gyrase inhibitors and uses thereof

    Expires Mon Aug 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  31. US 6593357

    Pyrazole compositions useful as inhibitors of ERK

    Expires Mon Jul 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  32. US 6586257

    Multiwell scanner and scanning method

    Expires Mon Jun 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  33. US 6576614

    Peptide analogs as irreversible interleukin-1&bgr; protease inhibitors

    Expires Mon Jun 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  34. US 6573259

    Inhibitors of interleukin-1&bgr; converting enzyme

    Expires Mon May 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  35. US 6559137

    Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors

    Expires Mon May 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  36. US 6552041

    Cyclized amide derivatives

    Expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  37. US 6541496

    Inhibitors of IMPDH enzyme

    Expires Mon Mar 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  38. US 6531474

    Inhibitors of caspases

    Expires Mon Mar 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  39. US 6528509

    Pyrazole compositions useful as inhibitors of ERK

    Expires Mon Feb 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  40. US 6528508

    Inhibitors of p38

    Expires Mon Feb 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  41. US 6528533

    Azo amino acids derivatives

    Expires Mon Feb 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  42. US 6518291

    Inhibitors of IMPDH enzyme

    Expires Mon Feb 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  43. US 6509363

    Heterocyclic inhibitors of p38

    Expires Mon Jan 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  44. US 6498178

    Inhibitors of IMPDH enzyme

    Expires Mon Dec 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  45. US 6495582

    Isoxazole compositions useful as inhibitors of ERK

    Expires Mon Dec 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  46. US 6436989

    Prodrugs of aspartyl protease inhibitors

    Expires Mon Aug 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  47. US 6426413

    Inhibitors of caspases

    Expires Mon Jul 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  48. US 6423840

    Inhibitors of interleukin-1&bgr; converting enzyme

    Expires Mon Jul 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Vertex Pharmaceuticals (Australia) have?

991 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Vertex Pharmaceuticals (Australia) patents expire?

63 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.